• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

FTC

Graphic image of the words try again on a purple background with some pixelated art below
Biotech

Sanofi CEO does not rule out future Pompe BD despite FTC moves

Sanofi CEO Paul Hudson said the company's M&A and business development strategy remains focused on the best science, despite recent FTC moves.
Max Bayer Jan 10, 2024 3:37pm
Illumina hq

Illumina sets a date to divest Grail

Dec 18, 2023 11:12am
end of the road road block shut down closed blocked

Sanofi scraps Maze deal after FTC throws up antitrust obstacles

Dec 12, 2023 6:00am
Illumina hq

Illumina CEO Francis deSouza resigns after proxy battle

Jun 12, 2023 10:30am
Illumina hq

Illumina wins FTC antitrust case over Grail acquisition

Sep 1, 2022 1:50pm
FTC building

FTC orders Medtronic to sell off Intersect ENT subsidiary

May 11, 2022 12:05pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings